This Article Full Text Full Text (PDF) Correction (v111,p378) All Versions of this Article: 110/11/1473    most recent 01.CIR.0000134961.36773.D6v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Bauer, F. Articles by Cribier, A. Search for Related Content PubMed PubMed Citation Articles by Bauer, F. Articles by Cribier, A. Related Collections Contractile function Other heart failure Other Treatment Echocardiography CV surgery: aortic and vascular disease CV surgery: other Related Article

(Circulation. 2004;110:1473-1476.)
© 2004 American Heart Association, Inc.

Original Articles

Acute Improvement in Global and Regional Left Ventricular Systolic Function After Percutaneous Heart Valve Implantation in Patients With Symptomatic Aortic Stenosis

Fabrice Bauer, MD; Hélène Eltchaninoff, MD; Christophe Tron, MD; Pierre-François Lesault, MD; Carla Agatiello, MD; Deborah Nercolini, MD; Geneviève Derumeaux, MD; Alain Cribier, MD

From the Department of Cardiology, Hôpital Charles Nicolle, Rouen, France.

Correspondence to Fabrice Bauer, MD, Cardiology Department, Echocardiography Core Lab, Hôpital Charles Nicolle, 1 rue de Germont, 76031 Rouen, France. E-mail fabrice.bauer{at}chu-rouen.fr

Received March 22, 2004; revision received May 24, 2004; accepted May 25, 2004.

Background— The newly developed percutaneous heart valve (PHV) implantation technique decreases transaortic pressure gradient in patients with aortic stenosis. PHV replacement effects on left ventricular (LV) global and regional systolic function are currently unknown.

Methods and Results— Eight patients with severe aortic stenosis had 2D echocardiography at baseline and 24 hours after PHV implantation to evaluate changes in LV volume and LV ejection fraction. Regional function, ie, both peak systolic anterior and posterior wall tissue velocity, as well as strain and strain rate imaging, were measured by tissue Doppler imaging from a short-axis view. At 24 hours, a significant reduction in transaortic mean pressure gradient (from 46±15 to 8±3 mm Hg; P<0.0001) was accompanied by an increase in aortic valve area (from 0.59±0.11 to 1.69±0.11 cm²; P<0.0001). LV end-diastolic volume remained unchanged (102±36 to 101±12 mL; P=NS), whereas LV ejection fraction increased (48±18% to 57±12%; P<0.01). Improvement in posterior wall displacement (posterior wall tissue velocity increased from 2.2±0.5 to 4.4±1.0 cm/s^–1; P=0.0003) and deformation (strain rate imaging increased from 1.0±0.3 to 1.9±0.7 s^–1, P=0.009, and strain increased from 11±5% to 17±9%; P=0.02) were observed.

Conclusions— Immediately after PHV replacement, improvement of LV global and regional systolic function was evidenced by tissue Doppler imaging.

Key Words: systole • aorta • stenosis • echocardiography • valves

Related Article:

Circulation 2004 110: 1337. [Extract] [Full Text]

This article has been cited by other articles:

				S. Lafitte, M. Perlant, P. Reant, K. Serri, H. Douard, A. DeMaria, and R. Roudaut Impact of impaired myocardial deformations on exercise tolerance and prognosis in patients with asymptomatic aortic stenosis Eur J Echocardiogr, May 1, 2009; 10(3): 414 - 419. [Abstract] [Full Text] [PDF]

				J. G. Webb Percutaneous Aortic Valve Replacement Will Become a Common Treatment for Aortic Valve Disease J. Am. Coll. Cardiol. Intv., April 1, 2008; 1(2): 122 - 126. [Abstract] [Full Text] [PDF]

				T. Walther, P. Simon, T. Dewey, G. Wimmer-Greinecker, V. Falk, M. T. Kasimir, M. Doss, M. A. Borger, G. Schuler, D. Glogar, et al. Transapical Minimally Invasive Aortic Valve Implantation: Multicenter Experience Circulation, September 11, 2007; 116(11_suppl): I-240 - I-245. [Abstract] [Full Text] [PDF]

				L. Coats and P. Bonhoeffer NEW PERCUTANEOUS TREATMENTS FOR VALVE DISEASE Heart, May 1, 2007; 93(5): 639 - 644. [Full Text] [PDF]

				T. Walther, V. Falk, M. A. Borger, T. Dewey, G. Wimmer-Greinecker, G. Schuler, M. Mack, and F. W. Mohr Minimally invasive transapical beating heart aortic valve implantation -- proof of concept Eur. J. Cardiothorac. Surg., January 1, 2007; 31(1): 9 - 15. [Abstract] [Full Text] [PDF]

				E. Grube, J. C. Laborde, U. Gerckens, T. Felderhoff, B. Sauren, L. Buellesfeld, R. Mueller, M. Menichelli, T. Schmidt, B. Zickmann, et al. Percutaneous Implantation of the CoreValve Self-Expanding Valve Prosthesis in High-Risk Patients With Aortic Valve Disease: The Siegburg First-in-Man Study Circulation, October 10, 2006; 114(15): 1616 - 1624. [Abstract] [Full Text] [PDF]

				T. M. Dewey, T. Walther, M. Doss, D. Brown, W. H. Ryan, L. Svensson, T. Mihaljevic, R. Hambrecht, G. Schuler, G. Wimmer-Greinecker, et al. Transapical aortic valve implantation: an animal feasibility study. Ann. Thorac. Surg., July 1, 2006; 82(1): 110 - 116. [Abstract] [Full Text] [PDF]

				T. Walther, T. Dewey, G. Wimmer-Greinecker, M. Doss, R. Hambrecht, G. Schuler, F. W. Mohr, and M. Mack Transapical approach for sutureless stent-fixed aortic valve implantation: experimental results. Eur. J. Cardiothorac. Surg., May 1, 2006; 29(5): 703 - 708. [Abstract] [Full Text] [PDF]

				T. H. Marwick Measurement of Strain and Strain Rate by Echocardiography: Ready for Prime Time? J. Am. Coll. Cardiol., April 4, 2006; 47(7): 1313 - 1327. [Abstract] [Full Text] [PDF]

				A. Cribier, H. Eltchaninoff, C. Tron, F. Bauer, C. Agatiello, D. Nercolini, S. Tapiero, P.-Y. Litzler, J.-P. Bessou, and V. Babaliaros Treatment of Calcific Aortic Stenosis With the Percutaneous Heart Valve: Mid-Term Follow-Up From the Initial Feasibility Studies: The French Experience J. Am. Coll. Cardiol., March 21, 2006; 47(6): 1214 - 1223. [Abstract] [Full Text] [PDF]